Pascal Chanez spends much of his time researching Asthma, Immunology, Internal medicine, Respiratory disease and COPD. His studies in Asthma integrate themes in fields like Physical therapy, Severity of illness and Randomized controlled trial. He combines subjects such as Chronic bronchitis and Bronchoalveolar lavage with his study of Immunology.
His Internal medicine research includes themes of Placebo, Surgery, Airway and Endocrinology. The study incorporates disciplines such as Mepolizumab and Exacerbation in addition to Placebo. Pascal Chanez has included themes like Lipoxin, Biopsy, Immunopathology, Monoclonal antibody and Eicosanoid in his Respiratory disease study.
His main research concerns Asthma, Immunology, Internal medicine, COPD and Inflammation. His Asthma study combines topics in areas such as Respiratory disease, Airway, Cohort and Intensive care medicine. The concepts of his Intensive care medicine study are interwoven with issues in Disease and MEDLINE.
His Immunology research includes elements of Sputum and Bronchoalveolar lavage, Lung. Pascal Chanez interconnects Gastroenterology, Placebo, Endocrinology and Physical therapy in the investigation of issues within Internal medicine. The various areas that he examines in his Placebo study include Mepolizumab and Adverse effect.
Pascal Chanez mostly deals with Internal medicine, Asthma, Immunology, Severe asthma and Cohort. His Internal medicine research incorporates elements of Gastroenterology and Placebo. Pascal Chanez studies Asthma, focusing on Endotype in particular.
In his study, which falls under the umbrella issue of Immunology, Eosinophil is strongly linked to Sputum. His work on Bronchial thermoplasty as part of his general Severe asthma study is frequently connected to In patient, thereby bridging the divide between different branches of science. Pascal Chanez works mostly in the field of Cohort, limiting it down to topics relating to COPD and, in certain cases, Cardiology and Mortality rate.
His scientific interests lie mostly in Asthma, Internal medicine, Eosinophil, Immunology and Severe asthma. His study on Asthma also encompasses disciplines like
His work carried out in the field of Eosinophil brings together such families of science as Mast cell, Inflammation, Immune system and Respiratory system. Pascal Chanez combines subjects such as Sputum, Transcription factor, Disease and Lung with his study of Immunology. His work on Bronchial thermoplasty as part of general Severe asthma study is frequently linked to Breath gas analysis, bridging the gap between disciplines.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Eosinophilic inflammation in asthma.
J Bousquet;P Chanez;J Y Lacoste;G Barnéon.
The New England Journal of Medicine (1990)
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Kian Fan Chung;Sally E. Wenzel;Jan L. Brozek;Andrew Bush.
European Respiratory Journal (2014)
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial.
Ian D Pavord;Stephanie Korn;Peter Howarth;Eugene R Bleecker.
The Lancet (2012)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega;Mark C. Liu;Ian D. Pavord;Guy G. Brusselle.
The New England Journal of Medicine (2014)
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.
Helen K. Reddel;D. Robin Taylor;Eric D. Bateman;Louis-Philippe Boulet.
American Journal of Respiratory and Critical Care Medicine (2009)
Induction of nitric oxide synthase in asthma
Q Hamid;Springall;JM Polak;V Riveros-Moreno.
The Lancet (1993)
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial
Eugene R Bleecker;J Mark FitzGerald;Pascal Chanez;Alberto Papi.
The Lancet (2016)
Transforming Growth Factor- β Expression in Mucosal Biopsies in Asthma and Chronic Bronchitis
A M Vignola;P Chanez;G Chiappara;A Merendino.
American Journal of Respiratory and Critical Care Medicine (1997)
Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
Helgo Magnussen;Bernd Disse;Roberto Rodriguez-Roisin;Anne Kirsten.
The New England Journal of Medicine (2014)
A new perspective on concepts of asthma severity and control
D. R. Taylor;E. D. Bateman;L.-P. Boulet;H. A. Boushey.
European Respiratory Journal (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: